Member Info for WeTookPelham

@C7 - Some funny goings on IMO.

@c7, my small 4k approx top up yesterday morning almost certainly caused an up tick yesterday judging by the time and price I bought at, so IMO* it's possible these 1k sells would have a similar inverse affect? I.e. taking the SP down/taking the shine off upticks? MM's in firm control?

*I know nothing as usual

Hi C7, I posted wondering about the pattern of these 1k sells, any thoughts?

All this talk about challenge studies and injecting the virus, won't the predicted second wave and even the new current spikes in infections provide more than enough suitable candidates?

https://www.theguardian.com/science/2020/jul/16/covid-19-vaccine-what-have-we-learned-from-oxford-phase-one-trial

"...Phase one human trials of a Covid-19 vaccine being developed by researchers at the University of Oxford suggest it triggers two types of immune response, unnamed sources working on the vaccine told ITV’s Robert Peston. Not only does the jab trigger the production of antibodies – proteins that can bind to the virus, preventing it from entering cells and flagging it to immune cells – but it also seems to result in the production of “killer” T cells – immune cells that attack infected human cells."

"What does this mean for immunity?
So far, that is unclear, and some scientists have been unwilling to comment on the findings on the Oxford vaccine, at least until the full study is published in the Lancet on Monday. But one thing is for sure: there is still a long way to go to show that the Oxford vaccine can guard against Covid-19, despite hopes that it could be ready by September. “The big next steps will be to head into appraisal of actual protection,” said Altmann.

Stamataki agreed, noting that the two key questions were whether the immune responses generated by the various vaccines under development can protect against severe disease, and if so, for how long."

P.s. @bunsie - this may help your "How does that compare to Covidity?" question

https://www.sciencedaily.com/releases/2020/07/200715095500.htm

https://www.ft.com/content/2aec0597-1de3-4181-93a0-1da9483d8b26

Anyone here an FT subscriber? Very interesting headline.

...towards the end of the day, but another 1x 1k sell just towards 4:30, there was a barrage of these last night, what's that about? Is someone keen to keep the SP down/neutral? Surely banking £50 minus fees isn't going to make much difference to anyone, especially as it's likely to be at a loss too?

https://www.youtube.com/watch?v=TsKiYIK2dZ4

Scroll back about 10-15 min

Dalester, any chance you can join the Scancell board? :) Your logical thinking seems to be totally absent!

Apologies Dieter Hovekamp's responses was to this tweet:
https://twitter.com/RNAiAnalyst/status/1283372831934480384
"Dirk Haussecker
@RNAiAnalyst
·
Jul 15, 2020
$mrna $bntx as long as they can maintain their early mover advantage, they should garner some market share early on- barring some catastrophic allergic reactions in the phase III studies.

After that+for yearly admin, expect them to be fringe players.

$nvax $ino"

That could prick a a few ears :)

https://twitter.com/dhovekamp42/status/1283377445194866695
************************************************
`((,(Dieter 'Hovekamp)))
@dhovekamp42
Also note $BNTX might have access to an other platform currently not on focus but licensed for cancer already from $SCLP seeking funding https://twitter.com/wtp1235/status/1283351832044154880?s=20

Calculus Capital
@CalculusCapital
Lindy Durrant, CSO at @scancellpharma and has developed a vaccine that prompts a T-cell response and virus-neutralising antibodies against Sars-Cov-2. Scancell believes the combination could lead to longer-lasting immunity https://bit.ly/2LIXhcD
1:26 PM · Jul 15, 2020
***********************************
Seen him post before, seems to be a big fan of scancell, and some great tweets/retweets/articles on his own page:
https://twitter.com/dhovekamp42

Knowlesi - no, what your feeling is proably DP getting too close to you from behind, he's been on his medication.

Hi C7, so is 5.10 "gap" now closed? (From the covid RNS day)
Onwards and upwards!?

Bravo DP...bravo.

Interestingly, it seems Pestons "leak" has caused an upick in Astras SP (and the market in general too?) The power of a tweet eh?

https://twitter.com/peterhaughton/status/1283344370582851585
https://twitter.com/forexflowlive/status/1283346317029150720
https://citywire.co.uk/wealth-manager/news/ftse-rallies-2-on-double-dose-of-coronavirus-vaccine-hopes/a1380613/print?section=wealth-manager

I wonder if Robbie P has shares in Astra ;)
(Ok ok...I know i know....maybe i need to take my happy pills now)

RE peston tweet -
Ah...i stand corrected...i think?

Hi Bermuda, i will have look thanks. But according to that article (yes, again) - https://www.researchprofessionalnews.com/rr-news-uk-politics-whitehall-2020-6-mystery-over-who-approved-126m-vaccine-investment/

"But funding for the university-led projects at Oxford and Imperial did not go through the usual UKRI granting mechanisms and all the departments or bodies involved in Covid-19 response have declined to answer questions about what peer review—if any—was involved in the decisions. Other vaccine efforts, including one at a spinout from University of Bristol, and another one at University of Nottingham have had no government funding for their efforts."

Are they wrong then?

p.s. my first comment on the peston tweet just mentioned that Nottingham/Scancell were woking on a vaccine specifically in the T-cell arena, didnt mention anything about funding...wasn't shown on his feed. Re-commented again, this time mentioned funding (and a little more insistent), again not shown. As i say, make what you will, but it fufills my conspiracy quota for the day :)

Well i'll come out and say it, I think there is (IMO) complete and obvious bias towards Oxford as an institution and therefore it's vaccine. As RayP mentioned theres no way of proving this obviously however, but:
- "So" many government connections to Oxford - head of the vaccine task force for one
- The balance/sharing of funds
- The sudden lack of urgency to find alternatives to Oxfords and Imperials approches
And i keep going back to this article as it sums up everyhing IMO:
https://www.researchprofessionalnews.com/rr-news-uk-politics-whitehall-2020-6-mystery-over-who-approved-126m-vaccine-investment/

Not a ounce of apprasial or assemessment - just "here's x million oxford & imperial, do as you please". Where every other institution had to apply and be assessed. That might be an over-simplification but you get what I mean.
But most of all my reason for doubting the impartiality of it is that we've seen just how corrupt/bias the goverment is in terms of handing out contracts, just have a look at how many organisations with links to cummings have won government contracts:
https://www.crowdjustice.com/case/a-river-to-my-people/

So i find it hard to believe there is no bias here...but again all IMO. And as I always say...I know nothing.

p.s. @Bermuda, glad to hear you havent blocked me though!